Now showing items 1-8 of 8
Law and policy director Gail Javitt presents comments at the Food and Drug Administration hearing on Consumer-Directed Promotion of Regulated Medical Products
(Genetics and Public Policy Center, 2005-11-01)
Law and policy director Gail Javitt public comments before the Secretary's Advisory Committee on Genetics Health and Society
(Genetics and Public Policy Center, 2006-03-27)
Public Health at Risk: Failures in Oversight of Genetic Testing Laboratories
(Genetics and Public Policy Center, 2006-09)
The Human Genome Project unleashed a torrent of information about the human genome and the role of genetic variation in human health. As a result, genetic testing is now among the fastest growing areas of laboratory medicine. ...
Reproductive Genetic Testing: Issues and Options for Policymakers
(Genetics and Public Policy Center, 2005)
Reproductive genetic testing offers prospective parents information about their risk of having a child with a genetic disease or characteristic. This information can be used to help prospective parents make reproductive ...
Preimplantation Genetic Diagnosis: A Discussion of Challenges, Concerns, and Preliminary Policy Options Related to the Genetic Testing of Human Embryos
(Genetics and Public Policy Center, 2004)
A report by the Genetics and Public Policy Center at Johns Hopkins University outlines policy options to address the scientific and ethical challenges raised by genetic testing of human embryos. The report will be released ...
Genetic tests are testing the law
(Genetics and Public Policy Center, 2006)
Genetic testing technology has brought new hope—and reproductive options—to would-be parents. But when a testing error occurs or the results are misread or miscommunicated, children may be born with severe, lifelong ...
Law and policy director Gail Javitt public comments on FDA's Draft Guidance for Industry and FDA Staff: Pharmacogenetic Tests and Genetic Tests for Heritable Markers
(Genetics and Public Policy Center, 2006-05-10)